Consequently, blocking HER1/EGFR tyrosine kinase signaling has been found to inhibit the growth and metastasis of human pancreatic tumor xenografts [9] and enhance the antitumor effects of gemcitabine [10]. This evidence concerns the gene EGFR and pancreatic neoplasm.